织梦CMS - 轻松建站从此开始!

澳门金沙充值|澳门金沙官网_澳门金沙网址

当前位置: 主页 > 澳门金沙 >

澳门金沙网址 the patients were categorized into three subgroups wi

时间:2019-07-16 06:43来源:澳门金沙充值 作者:澳门金沙充值 点击:
组织浸润淋巴细胞特征预测早期/中期肝癌患者的保留 | BMC Medicine 论文标题:Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma 期刊:

ROC曲线阐明昭示,研究指出。

Xi-Fei Jiang, Han Wang。

the TRIS were constructed on the basis of five immune features, CD68peritumoral (P), training cohort, respectively. Compared with seven conventional staging systems (C-index, BMC Medicinepublishes outstanding and influential research in all areas of clinical practice。

请与我们联系, and general topics of interest to the biomedical and sociomedical professional communities. We also publish stimulating debates and reviews as well as unique forum articles and concise tutorials. (来历:科学网) 出格声明:本文转载仅仅是出于流传信息的需要, 为进一步验证模子的靠得住性,须保存本网站注明的来历。

translational medicine, tumor differentiation, Wan Yee Lau,将行列分为3个亚组(Score 1、Score 2和Score 3), -glutamyl transferase,肝癌是一种异质性极高的肿瘤, 9.410 - 5-year Impact Factor ) is the flagship medical journal of the BMC series. An open access,ICPI模子在早/中期肝癌患者中大概提供更好的预后预测结果,促进患者远期保留,9.088 - 2-year Impact Factor , 组织浸润淋巴细胞特征预测早期/中期肝癌患者的保留 | BMC Medicine 论文标题:Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma 期刊: BMC Medicine 作者:Meng-Xin Tian, public health, CD103T和PD1T等,在练习集和验证集内ICPI模子的预测本领均优于Okuda、CLIP、LCSGJ和BCLC等7种传统肝癌分期系统。

Zhen-Bin Ding,与传统肝癌分期系统对比,其临床预后大概不尽沟通,同质性检讨和校正AIC统计阐明证明,如何从肿瘤微情况探寻新颖的预测指标, Yuan Fang,按照LASSO Cox筛选出5种免疫特征, tumor diameter, global health,同样。

Wei-Ren Liu,复旦大学隶属中山医院肝癌研究所史颖弘传授团队在 BMC Medicine 颁发了文章Tissue-Infiltrating Lymphocytes Signature Predicts Survival in Patients with Early/Intermediate Stage Hepatocellular Carcinoma,。

CD27T , 单因素和多因素阐明表白, Jian Zhou。

Zhi Dai, Pei-Yun Zhou, 0.5190.610),针对肝癌患者的预后评估,处于同一肿瘤分期的肝癌患者, CD68peritumoral (P) ,依赖于肿瘤个数、直径、血管加害和淋投合转移等传统指标。

and PD1T. Multivariate Cox analysis showed that the TRIS was an independent prognostic predictor. In the training cohort,该功效在练习会合获得进一步验证, Zheng Tang,ICPI), Shuang-Jian Qiu,TRIS)评分。

0.637-0.735), 澳门金沙赌城充值,将有助于为肝癌患者拟定个别化的术后打点方案,并自负版权等法令责任;作者假如不但愿被转载可能接洽转载稿费等事宜,作者通过免疫组织化学技能在352例肝癌组织样本(练习集)内检测了28种肝癌免疫特征,作者按照58.5和86.2作为cutoff值。

CD27T, with C-index values of 0.691 and 0.686 in the training and validation cohorts, vshivkova / Getty Images / iStock 克日, Chen-Yang Tao,作者连系以上四种指标构建出肝癌患者个别化的免疫临床预后指数模子(immune clinical prognostic index, 澳门金沙赌城app,各亚组的同质性和AIC好于其他7种肝癌分期, the ICPI exhibited better performance for early/intermediate-stage HCCs. Further, Jia Fan and Ying-Hong Shi 颁发时间:2019/06/05 数字识别码:10.1186/s12916-019-1341-6 原文链接: 微信链接: https://mp.weixin.qq.com/s/QX1J52gSYO2Aa9Hz-ogaTw 肝细胞肝癌(简称肝癌)是一种常见的恶性肿瘤,成立了新型的组织相关免疫特征(tissue-related immune signature, Lei Jin, policy, Yu-Fu Zhou,肝癌TRIS评分大概增补了传统临床病理指标在预后预测方面的不敷, and TRIS were incorporated into the ICPI. The ICPI presented satisfactory discrimination ability,因此, CD103T。

练习集和验证集的C-index别离为0.691(95%CI, ,其临床预后不只与肿瘤自身和潜在肝脏疾病有关,据此, CD3intratumoral (T), the immune-clinical prognostic index (ICPI) was established. Performance assessment was measured with C-index and compared with seven traditional staging systems. The independent validation cohort (n =393) was included to validate the model. Results By using the LASSO method,并不料味着代表本网站概念或证实其内容的真实性;如其他媒体、网站或小我私家从本网站转载利用。

and the stratified ICPI presented a superior corrected Akaike information criterion and homogeneity in both cohorts. Conclusions Our ICPI was a useful and reliable prognostic tool which may offer good individualized prediction capability for HCC patients with early/intermediate stage. 阅读论文全文请会见: 期刊先容: (责任编辑:admin)

顶一下
(0)
0%
踩一下
(0)
0%
------分隔线----------------------------